Modes of resistance to anti-angiogenic therapy

Bergers, Gabriele, Hanahan, Douglas·2008·Nature Reviews Cancer

DOI 10.1038/nrc2442

Cited by (1,005)

Items 501–600 of 1,005

Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy
Erqi Liu Pollom, Lei Deng, Reetesh K. Pai, J. Martin Brown, Amato J. Giaccia, Billy W. Loo, David Benjamin Shultz, Quynh‐Thu Le, Albert C. Koong, Daniel Tandel Chang · 2015 · International Journal of Radiation Oncology*Biology*Physics
Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2
Eugene J. Fine, Anna A. M. Miller, Edward V. Quadros, Jeffrey M. Sequeira, Richard David Feinman · 2009 · Cancer Cell International
Multifaceted roles of Adiponectin in cancer
Lionel Hebbard, Barbara Ranscht · 2013 · Best Practice & Research Clinical Endocrinology & Metabolism
Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
Ruman Rahman, Stuart James Smith, Cheryl V. Rahman, Richard Guy Grundy · 2010 · Journal of Oncology
Dll4-Notch signaling in regulation of tumor angiogenesis
Zhaoguo Liu, Fangtian Fan, Aiyun Wang, Shizhong Zheng, Yin Lu · 2013 · Journal of Cancer Research and Clinical Oncology
Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches
Kjell Öberg, Oriol Casanovas, Justo Pastor Castano, Daniel C. Chung, Gianfranco Delle Fave, Patrice Denèfle, Philip A. Harris, Mohid Shakil Khan, Matthew H. Kulke, Aldo Scarpa et al. · 2013 · Clinical Cancer Research
Endothelial Cell Glucose Metabolism and Angiogenesis
Wa Du, Lü Ren, Milton H. Hamblin, Yanbo Fan · 2021 · Biomedicines
Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment
Joanne Tze Chin Lim, Leng Gek Kwang, Nicholas Ching Wei Ho, Clarissa Chin Min Toh, Nathaniel Sheng Hua Too, Lissa Hooi, Touati Benoukraf, Pierce K. H. Chow, Yock Young Dan, Edward Kai‐Hua Chow et al. · 2022 · Biomaterials
Metal-based nanoparticle in cancer treatment: lessons learned and challenges
Ali Hheidari, Javad Mohammadi, Maryam Ghodousi, Mohammadreza Mahmoodi, Sina Ebrahimi, Esmail Pishbin, Abbas Rahdar · 2024 · Frontiers in Bioengineering and Biotechnology
Personalized Vascularized Tumor Organoid‐on‐a‐Chip for Tumor Metastasis and Therapeutic Targeting Assessment
Yang Du, Yi‐Ran Wang, Qiyuan Bao, Xinxin Xu, Congling Xu, Shaoxuan Wang, Qi Liu, Fan Liu, Yu‐Lian Zeng, Yajun Wang et al. · 2024 · Advanced Materials
Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy
Hui Min Xu, Shervin Rahimpour, Cody L. Nesvick, Xu Zhang, Jingyun Ma, Min Zhang, Ge Zhang, Li Wang, Chunzhang Yang, Christopher S. Hong et al. · 2015 · Oncotarget
Combretastatin A4 Phosphate: A Novel Vascular Disrupting Agent
Govardhanan Nagaiah, Scot C. Remick · 2010 · Future Oncology
Angiogenesis: A Target in Solid Tumors, Also in Leukemia?
Thomas Schmidt, Peter Carmeliet · 2011 · Hematology
Endoglin for Targeted Cancer Treatment
Lee S. Rosen, Michael S. Gordon, Francisco Robert, Daniela Elena Matei · 2014 · Current Oncology Reports
Vascular disrupting agents in cancer therapy
Ryszard Smolarczyk, Justyna Czapla, Magdalena Jarosz–Biej, Kyle Czerwinski, Tomasz Cichoń · 2020 · European Journal of Pharmacology
A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy
Frédérique Billy, Benjamin Ribba, Olivier Saut, Hélène Morre-Trouilhet, Thierry Colin, Didier Bresch, Jean‐Pierre Boissel, Emmanuel Grenier, Jean‐Pierre Flandrois · 2009 · Journal of Theoretical Biology
Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models
Laura G.M. Daenen, Yuval Shaked, Shan Man, Ping Xu, Emile E. Voest, Robert M. Hoffman, David J. Chaplin, Robert S. Kerbel · 2009 · Molecular Cancer Therapeutics
Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature
Hooglugt, Aukie, van der Stoel, Miesje M., Boon, Reinier A., Huveneers, Stephan · 2021 · Frontiers in Oncology
Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer
Bruce G. Robinson, Martin Jean Schlumberger, Lori J. Wirth, Corina E. Dutcus, James Song, Matthew Hiram Taylor, Sung‐Bae Kim, Monika Karolina Krzyzanowska, Jaume Capdevila, Steven I. Sherman et al. · 2016 · The Journal of Clinical Endocrinology & Metabolism
Targeting vascular normalization: a promising strategy to improve immune–vascular crosstalk in cancer immunotherapy
Cheng Qian, Chaoqun Liu, Weiwei Liu, Rui Zhou, Liang Zhao · 2023 · Frontiers in Immunology
Angiogenesis and Current Antiangiogenic Strategies for the Treatment of Cancer
Rahmi Öklü, Thomas G. Walker, Stéphan Wicky, Robin Hesketh · 2010 · Journal of Vascular and Interventional Radiology
Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk
H. Chen, Dan Liu, Z. Yang, Limin Sun, Qinqin Deng, S. Yang, L. Qian, Liang Guo, M. Yu, M. Hu et al. · 2014 · Endocrine Related Cancer
Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
Jiawei Sun, Lei Jiang, Yi Lin, Ethan Michael Gerhard, Xuehua Jiang, Li Li, Jian Yu Yang, Zhongwei Gu · 2017 · International Journal of Nanomedicine
Angiopoietin‐2 drives lymphatic metastasis of pancreatic cancer
Petra M. Schulz, Christian Fischer, Katharina M Detjen, Svenja Rieke, Georg Hilfenhaus, Zofia von Marschall, Michael Böhmig, Inga Koch, Jenny Kehrberger, Peter Hauff et al. · 2011 · The FASEB Journal
Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
Dalil Hannani, Antonella Sistigu, Oliver Kepp, Lorenzo Galluzzi, Guido Kroemer, Laurence Zitvogel · 2011 · The Cancer Journal
Phase II Clinical and Pharmacokinetic Study of Aflibercept in Patients with Previously Treated Metastatic Colorectal Cancer
Patricia A. Tang, Steven J. Cohen, Christian Kollmannsberger, Georg A. Bjarnason, Kiran Virik, Mary J. MacKenzie, Lillian Lourenço, Lisa E. Wang, Alice P. Chen, Malcolm J. Moore · 2012 · Clinical Cancer Research
Molecular targeted therapy for hepatocellular carcinoma: Current and future
Jung Woo Shin · 2013 · World Journal of Gastroenterology
Molecular Engineering‐Based Aptamer–Drug Conjugates with Accurate Tunability of Drug Ratios for Drug Combination Targeted Cancer Therapy
Fang Zhou, Peng Wang, Yongbo Peng, Pengge Zhang, Qin Huang, Weidi Sun, Nongyue He, Ting Fu, Zilong Zhao, Xiaohong Fang et al. · 2019 · Angewandte Chemie International Edition
The Emerging Roles of Pericytes in Modulating Tumor Microenvironment
Ruipu Sun, Xiangzhan Kong, Xiaoyi Qiu, Cheng Huang, Ping‐Pui Wong · 2021 · Frontiers in Cell and Developmental Biology
Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Ai‐Ming Yu, Mei‐Juan Tu · 2021 · Pharmacology & Therapeutics
Endogenous Angiogenesis Inhibitor Vasohibin1 Exhibits Broad-Spectrum Antilymphangiogenic Activity and Suppresses Lymph Node Metastasis
Takahiro Heishi, Tomoko Hosaka, Yasuhiro Suzuki, Hiroki Miyashita, Yuichi Oike, Takashi Takahashi, Takumi Nakamura, Shingo Arioka, Yuichi Mitsuda, Tomoaki Takakura et al. · 2010 · American Journal Of Pathology
CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo
Manuel Koch, Fadi Hussein, A Woeste, Carsten Gründker, Karl Frontzek, Günter Emons, T Hawighorst · 2010 · Breast Cancer Research and Treatment
Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression
Loredana Albonici, Maria Gabriella Giganti, Andrea Modesti, Vittorio Manzari, Roberto Bei · 2019 · International Journal of Molecular Sciences
Cancer lessons from mice to humans
David A. Tuveson, Douglas Hanahan · 2011 · Nature
MEDI3617, a human anti-Angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models
Ching Ching Leow · 2012 · International Journal of Oncology
Focal adhesion kinase inhibitors are potent anti‐angiogenic agents
Miguel A. Cabrita, Laura Jones, Jennifer L. Quizi, Luc A. Sabourin, Bruce C. McKay, Christina Addison · 2011 · Molecular Oncology
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
Arman Jahangiri, Alan T. Nguyen, Ankush Chandra, Maxim K. Sidorov, Garima Yagnik, Jonathan W. Rick, Sung Won Han, William C. Chen, Patrick Michael Flanigan, Dina Schneidman‐Duhovny et al. · 2017 · Proceedings of the National Academy of Sciences
Biology and therapeutic targeting of tumour‐associated macrophages
Tim Beltraminelli, Michele De Palma · 2020 · The Journal of Pathology
How to improve exposure of tumor cells to drugs — Promoter drugs increase tumor uptake and penetration of effector drugs
Fabrizio Marcucci, Angelo Corti · 2011 · Advanced Drug Delivery Reviews
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes
Konrad R. Gabrusiewicz, Dan Liu, Nahir Cortes‐Santiago, Mohammad Belayat Hossain, Charles A. Conrad, Kenneth Aldape, Gregory N. Fuller, Frank C. Marini, Marta María Alonso, Miguel Angel Idoate et al. · 2014 · Oncotarget
Understanding and targeting resistance to anti-angiogenic therapies.
Jeffrey Melson Clarke, Herbert I. Hurwitz · 2013 · Europe PMC (PubMed Central)
Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy
Bahar Yetkin-Arik, Arnoud W. Kastelein, Ingeborg Klaassen, Charlotte H. J. R. Jansen, Yani P. Latul, Miloš Vittori, Aydan Bırı, Korhan Kahraman, Arjan W. Griffioen, Frédéric C. Amant et al. · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Tie2-expressing monocytes (TEMs): Novel targets and vehicles of anticancer therapy?
Michele De Palma, Luigi Naldini · 2009 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer
Zhang Liang, Xiaoen Wang, Andrea J. Bullock, Marcella Callea, Harleen Shah, Jiaxi Song, Kelli M. Moreno, Barbara Visentin, Douglas H. Deutschman, David C. Alsop et al. · 2015 · Clinical Cancer Research
Optimizing the Delivery of Cancer Drugs That Block Angiogenesis
Yihai Cao, Róbert Langer · 2010 · Science Translational Medicine
Targeted therapies for thyroid tumors
Steven I. Sherman · 2011 · Modern Pathology
Discovery of High-Affinity PDGF-VEGFR Interactions: Redefining RTK Dynamics
Spencer B. Mamer, Si Chen, Jared C. Weddell, Alexandra Palasz, Ashley Wittenkeller, Manu Kumar, P. I. Imoukhuede · 2017 · Scientific Reports
Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression
Zhanyao Tan, Kun Chen, Wenjiao Wu, Yanqing Zhou, Jinrong Zhu, Geyan Wu, Lixue Cao, Xin Zhang, Hongyu Guan, Yi Yang et al. · 2018 · Theranostics
Linking tumour angiogenesis and tumour immunity
Ashraf Ul Kabir, Madhav Subramanian, Yoojung Kwon, Kyunghee Choi · 2025 · Nature reviews. Immunology
Angiogenesis and antiangiogenic agents in cervical cancer
Federica Tomao, Federica Tomao, Luigi Rossi, Eleonora Zaccarelli, Davide Caruso, Federica Zoratto, Pierluigi Benedetti Panici, Anselmo Papa · 2014 · OncoTargets and Therapy
Serotonin activates angiogenic phosphorylation signaling in human endothelial cells
Ali Zamani, Zhican Qu · 2012 · FEBS Letters
Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence
Sunday S. Oladipupo, Song Hu, Andrea C. Santeford, Junjie Yao, Joanna R. Kovalski, Ralph V. Shohet, Konstantin Maslov, Lihong V. Wang, Jeffrey M. Arbeit · 2011 · Blood
Cancer stem cells: a new framework for the design of tumor therapies
Boyan K. Garvalov, Till Acker · 2010 · Journal of Molecular Medicine
Adiponectin Deficiency Limits Tumor Vascularization in the MMTV-PyV-mT Mouse Model of Mammary Cancer
Martin Sebastian Denzel, Lionel Hebbard, Gregory Shostak, Lawrence S. Shapiro, Robert D. Cardiff, Barbara Ranscht · 2009 · Clinical Cancer Research
Sustained delivery of proangiogenic microRNA‐132 by nanoparticle transfection improves endothelial cell transplantation
Devalliere, Julie, Chang, William G., Andrejecsk, Jillian W., Abrahimi, Parwiz, Cheng, Christopher J., Jane‐wit, Dan, Saltzman, W. Mark, Pober, Jordan S. · 2014 · The FASEB Journal
Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets
Evangelia Ioannidou, Michele Moschetta, Sidrah Shah, Jack Steven Parker, Mehmet Akif Öztürk, George Pappas‐Gogos, Matin Sheriff, Elie Rassy, Stergios Boussios · 2021 · International Journal of Molecular Sciences
Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis
Monica S. Chung, Sang Jun Han · 2022 · Frontiers in Global Women s Health
Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities
Niloufar Rashidi, Majid Davidson, Vasso Apostolopoulos, Kulmira Nurgali · 2024 · Journal of Drug Delivery Science and Technology
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
Monica Loi, Serena Marchiò, Pamela Becherini, Daniela Di Paolo, Marco Soster, Flavio Curnis, Chiara Brignole, Gabriella Pagnan, Patrizia Perri, Irene Caffa · 2010 · Journal of Controlled Release
Increased Efficacy of Breast Cancer Chemotherapy in Thrombocytopenic Mice
Mélanie Demers, Benoît Ho‐Tin‐Noé, Daphne Schatzberg, Janie J. Yang, Denisa D. Wagner · 2011 · Cancer Research
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine
Gabriella Lupo, Nunzia Caporarello, Melania Olivieri, Martina Cristaldi, Carla Motta, Vincenzo Bramanti, Roberto Avola, Mario Salmeri, Ferdinando Nicoletti, Carmelina Daniela Anfuso · 2017 · Frontiers in Pharmacology
Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid
Makoto Tahara, Martin Jean Schlumberger, Rossella Elisei, Mouhammed Amir Habra, Naomi Kiyota, Ralf Paschke, Corina E. Dutcus, Taro Hihara, Shannon M. McGrath, Mark Matijevic et al. · 2017 · European Journal of Cancer
A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment
Jen‐Shin Song, Chih-Chun Chang, Chien-Huang Wu, Trinh Kieu Dinh, Jiing‐Jyh Jan, Kuan‐Wei Huang, Ming‐Chen Chou, Ting-Yun Shiue, Kai‐Chia Yeh, Yi‐Yu Ke et al. · 2021 · Proceedings of the National Academy of Sciences
Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance
Jungeun Lim, Hanna Ching, Jeong‐Kee Yoon, Noo Li Jeon, YongTae Kim · 2021 · Nano Convergence
Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects
Dong Li, Kun Xie, Longzhen Zhang, Xuejing Yao, Hongwen Li, Qiaoyu Xu, Xin Wang, Jing Jiang, Jianmin Fang · 2016 · Cancer Letters
Targeting tumor vascularization: promising strategies for vascular normalization
Ruiqi Zheng, Feifan Li, Fengcen Li, Aihua Gong · 2021 · Journal of Cancer Research and Clinical Oncology
Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch
Brian A. Baldo, Nghia H. Pham · 2013 · Cancer and Metastasis Reviews
Targeted therapy of hepatocellular carcinoma: Present and future
Stephen Lam Chan, Winnie Yeo · 2012 · Journal of Gastroenterology and Hepatology
Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents
Gabriel Limaverde‐Sousa, Cinthya Sternberg, Carlos Gil Ferreira · 2013 · Cancer Treatment Reviews
Targeted therapies in colorectal cancer—an integrative view by PPPM
Suzanne Hagan, Maria C. M. Orr, Brendan J. Doyle · 2013 · The EPMA Journal
Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells
Edmund Chinchar, Kristina L. Makey, John Gibson, Fang Chen, Shelby A. Cole, GAIL C. MEGASON, Srinivassan Vijayakumar, Lucio Miele, Jianwei Gu · 2014 · Vascular Cell
Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance
Hisamichi Naito, Taku Wakabayashi, Hiroyasu Kidoya, Fumitaka Muramatsu, Kazuhiro Takara, Daisuke Eino, Keitaro Yamane, Tomohiro Iba, Nobuyuki Takakura · 2016 · Cancer Research
Endothelial sprouting, proliferation, or senescence: tipping the balance from physiology to pathology
Severin Mühleder, Macarena Fernández-Chacón, Irene García-Gónzalez, Rui Benedito · 2020 · Cellular and Molecular Life Sciences
TGFBI modulates tumour hypoxia and promotes breast cancer metastasis
Flavia Fico, Albert Santamaria‐Martínez · 2020 · Molecular Oncology
Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism
Fan Yang, Gloria Lee, Yi Fan · 2024 · Angiogenesis
miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma
Heba W. Z. Khella, Henriett Butz, Qiang Ding, Fabio Rotondo, Kenneth Evans, Peter Kupchak, Moyez Dharsee, Ashraf Latif, Maria Diamandis Pasic, Evi S. Lianidou et al. · 2015 · Molecular Therapy
CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels
Quanyin Hu, Xiaoling Gao, Ting Kang, Xingye Feng, Di Jiang, Yifan Tu, Qingxiang Song, Lei Yao, Xinguo Jiang, Hongzhuan Chen et al. · 2013 · Biomaterials
Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
Zofia Felicja Bielecka, Anna Malgorzata Czarnecka, Wojciech Solarek, Anna Kornakiewicz, Cezary A. Szczylik · 2014 · Current Signal Transduction Therapy
Treatment of metastatic cervical cancer: Future directions involving targeted agents
Iván Díaz-Padilla, Bradley J. Monk, Helen J MacKay, Ana Oaknin · 2012 · Critical Reviews in Oncology/Hematology
Imaging Key Biomarkers of Tumor Angiogenesis
Marina V. Backer, Joseph M. Backer · 2012 · Theranostics
Tumor microenvironment: becoming sick of Myc
Jonathan Richard Whitfield, Laura Soucek · 2011 · Cellular and Molecular Life Sciences
Pro‐ and antiangiogenic therapies: current status and clinical implications
Ruslan Rust, Christina Gantner, Martin E. Schwab · 2018 · The FASEB Journal
Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy
Cátia Rebelo de Almeida, Raquel Valente Mendes, Anna Pezzarossa, Joaquim Gago, Carlos Torres Carvalho, António Alves, Vitor Moreira Nunes, María José Brito, Maria João Cardoso, Joana Mourato Ribeiro et al. · 2020 · Communications Biology
Tumour vascular disrupting agents: combating treatment resistance
Gillian M. Tozer, Chryso Kanthou, Gemma Lewis, Vivien E. Prise, Borivoj Vojnovic, S A Hill · 2008 · British Journal of Radiology
Targeted therapy for gastric cancer: Molecular pathways and ongoing investigations
Wei Yang, Alexander Grenander Raufi, Samuel Jacob Klempner · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Metronomic chemotherapy from rationale to clinical studies: A dream or reality?
Antonio Gnoni, Nicola Silvestris, Antonella Licchetta, Daniele Santini, Mario Scartozzi, Roberto Ria, Salvatore Pisconti, Fausto Petrelli, Angelo Vacca, Vito Lorusso · 2015 · Critical Reviews in Oncology/Hematology
Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by VEGF -Mediated EZH2/VASH1 Pathway
Bin Huang, Manping Huang, Qin Li · 2019 · Technology in Cancer Research & Treatment
Myeloid derived suppressor cells
Todd J. Waldron, Jon G. Quatromoni, Tatiana A. Karakasheva, Sunil Kumar Singhal, Anil K. Rustgi · 2013 · OncoImmunology
Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference
Daniel S.W. Tan, Marco Gerlinger, Bin Tean Teh, Charles Swanton · 2010 · European Journal of Cancer
Bioeffects of Ultrasound-Stimulated Microbubbles on Endothelial Cells: Gene Expression Changes Associated with Radiation Enhancement In Vitro
Azza Al‐Mahrouki, Raffi Karshafian, Anoja Giles, Gregory Jan Czarnota · 2012 · Ultrasound in Medicine & Biology
Vascular Endothelial Growth Factor A Inhibition in Gastric Cancer
Do Joong Park, Nicholas J. Thomas, Changhwan Yoon, Sam S. Yoon · 2014 · Gastric Cancer
Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications
Yi Li, Ali Saad, Jennifer Leigh Clarke, Soonmee Cha · 2017 · Brain Tumor Research and Treatment
Modeling human tumor angiogenesis in a three-dimensional culture system
Giorgio Seano, Giulia Chiaverina, Paolo Armando Gagliardi, Laura di Blasio, Roberto Sessa, Federico Bussolino, Luca Primo · 2013 · Blood
Glioblastoma’s Next Top Model: Novel Culture Systems for Brain Cancer Radiotherapy Research
Seamus P. Caragher, Anthony J. Chalmers, Natividad Gomez-Roman · 2019 · Cancers
Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment
Veronica Mãdãlina Aspriţoiu, Ileana Stoica, Coralia Bleoţu, Carmen Cristina Diaconu · 2021 · Frontiers in Cell and Developmental Biology
The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer
Xiaoxia Zhu, Wen Zhou · 2015 · Frontiers in Endocrinology
Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors
Giorgio Colombo, Barbara Margosio, Laura Ragona, Marco A. C. Neves, Silvia Bonifacio, Douglas S. Annis, Matteo Stravalaci, Simona Tomaselli, Raffaella Giavazzi, Marco Rusnati et al. · 2010 · Journal of Biological Chemistry
Antiangiogenic Therapy for Glioblastoma
Elizabeth Robins Gerstner, Tracy T. Batchelor · 2012 · The Cancer Journal
Emerging Targeted Strategies in Advanced Hepatocellular Carcinoma
Richard Finn · 2013 · Seminars in Liver Disease
Active Immunotherapy Induces Antibody Responses That Target Tumor Angiogenesis
Jonathan Daniel Schoenfeld, Masahisa Jinushi, Yukoh Nakazaki, Daniel C. Wiener, Joosang Park, Robert J. Soiffer, Donna S Neuberg, Martín C. Mihm, Frank Stephen Hodi, Glenn Dranoff · 2010 · Cancer Research